HbO2 Therapeutics
Souderton · Founded 2014
About HbO2 Therapeutics
HbO2 Therapeutics develops and manufactures oxygen-carrying solutions, a class of drug products that when administered intravenously can increase the amount of oxygen transported throughout the body. It offers two products. Hemopure [hemoglobin glutamer – 250 (bovine)], for use in humans, and Oxyglobin [hemoglobin glutamer – 200 (bovine)]) for veterinary use. The company was founded in 2014 and is headquartered in Souderton, Pennsylvania.
Company Facts
- Founded: 2014
- Legal name: Hemoglobin Oxygen Therapeutics LLC
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Seed (Apr 2015)
- Website: hbo2therapeutics.com
- Phone: (267) 382-0064
Social Profiles
Canonical: https://fsome.com/organization/hbo2-therapeutics-8463352 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.